Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical ...

GeneDx Holdings (WGS) is poised for growth with strong Q2 results and SaaS transition. Read here for an investment analysis.

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials, say ...

In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.

Boston researchers sequenced a full human genome in record time, under four hours. The advance could speed life-saving diagnoses for newborns in intensive care. Boston Children’s Hospital, in ...

Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over ...

The prenatal and newborn genetic testing market is expanding due to technological advancements in non-invasive methods, rising awareness of genetic disorders, and supportive policies. Key ...

Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.